Company profile:
Shanghai Huiren Pharmaceutical Co., Ltd. was established on March 20, 2002 with a registered capital of 30 million yuan, and its legal representative is Chen Binglang. The address of the company is Room 396 102, Li Shizhen Road, China (Shanghai) Pilot Free Trade Zone, and the unified social credit code and tax number are 9 13 1065438. The registration authority is the branch of the Pilot Free Trade Zone, and its business scope covers the wholesale of proprietary Chinese medicines, chemical preparations, antibiotics, biochemical drugs, biological products (see the license for details), food circulation, medical device sales (see the license for details), cosmetics, chemical products (except dangerous chemicals, monitored chemicals, civil explosives and precursor chemicals) and daily necessities sales, conference services and commerce. Projects that must be approved according to law can only be operated after being approved by relevant departments. The industrial and commercial registration number of Shanghai Huiren Pharmaceutical Co., Ltd. is 3101000284334.
Branch:
Foreign investment:
Shareholders:
Huiren Group Co., Ltd. contributed 66.67%, and the subscribed capital contribution was 20 million yuan.
The contribution ratio of Shanghai Jiankun Pharmaceutical Co., Ltd. is 33.33%, and the subscribed capital contribution is 100000000.
Executives:
Chen Binglang is the chairman of the company.
Chen Binglang works in the company.
Luo Minghua is the general manager of this company.
Chennian is a director of the company.
Chen Jinglan is in charge of the company.